(Q41132595)

27 September 2017

Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection (English)

1 reference

27 September 2017

1 reference

1

1 reference

27 September 2017

Jiao S

2

1 reference

PubMed ID

9042532

27 September 2017

Collins F

series ordinal

3

1 reference

PubMed ID

9042532

27 September 2017

Miller PJ

series ordinal

4

1 reference

27 September 2017

1 January 1997

1 reference

27 September 2017

1 reference

27 September 2017

747

1 reference

27 September 2017

92-102

1 reference

27 September 2017

1

1 reference

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

Neurotrophins in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

Success and problems of long-term levodopa therapy in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901265-6

10.1016/S0006-8993(96)01265-6

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

9042532